Immunohistochemical and molecular subtypes of breast cancer in Nigeria.
about
The prevalence of estrogen receptor-negative breast cancer in Ethiopia.Breast cancer survival in Ethiopia: a cohort study of 1,070 women.Breast cancer histology and receptor status characterization in Asian Indian and Pakistani women in the U.S.--a SEER analysis.Protein expression profile and prevalence pattern of the molecular classes of breast cancer--a Saudi population based studyBreast cancer in Sub-Saharan Africa: opportunities for prevention.Stage at breast cancer diagnosis and distance from diagnostic hospital in a periurban setting: a South African public hospital case series of over 1,000 women.Receptor-defined subtypes of breast cancer in indigenous populations in Africa: a systematic review and meta-analysis.Molecular breast cancer subtypes prevalence in an indigenous Sub Saharan African population.Emerging breast cancer epidemic: evidence from AfricaBasal-like phenotype in a breast carcinoma case series from Sudan: prevalence and clinical/pathological correlations.Clinical and histopathological factors associated with Ki-67 expression in breast cancer patients.Very low prevalence of epidermal growth factor receptor (EGFR) protein expression and gene amplification in Saudi breast cancer patients.Challenges in the detection, prevention, and treatment of HIV-associated malignancies in low- and middle-income countries in Africa.A retrospective analysis of breast cancer subtype based on ER/PR and HER2 status in Ghanaian patients at the Korle Bu Teaching Hospital, Ghana.Aggressive breast cancer in western Kenya has early onset, high proliferation, and immune cell infiltration.Breast cancer in Kumasi, Ghana.First report on molecular breast cancer subtypes and their clinico-pathological characteristics in Eastern Morocco: series of 2260 cases.Parity and breastfeeding are protective against breast cancer in Nigerian women.Breast cancer characteristics and HIV among 1,092 women in Soweto, South Africa.Systematic review of breast cancer biology in developing countries (part 1): Africa, the middle East, eastern europe, Mexico, the Caribbean and South americaSystematic review of breast cancer biology in developing countries (part 2): asian subcontinent and South East Asia.Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer.Mastectomy for management of breast cancer in Ibadan, NigeriaBreast cancer receptor status and stage at diagnosis in over 1,200 consecutive public hospital patients in Soweto, South Africa: a case series.Cancer burden in Africa and opportunities for prevention.Hormone receptors and Her2 expression in breast cancer in sub-Saharan Africa. A comparative study of biopsies from Ghana and Norway.Tumor infiltrating leukocyte density is independent of tumor grade and molecular subtype in aggressive breast cancer of Western Kenya.Breast cancer in Angola, molecular subtypes: a first glanceMolecular characteristics and prognostic features of breast cancer in Nigerian compared with UK women.High incidence of triple-negative tumors in sub-saharan Africa: a prospective study of breast cancer characteristics and risk factors in Malian women seen in a Bamako university hospital.Breast cancer molecular subtypes as identified by immunohistochemistry in South African black women.Immunohistochemistry defined subtypes of breast cancer in 678 Sudanese and Eritrean women; hospitals based case series.Correlation of Hormone Receptor and Human Epidermal Growth Factor Receptor-2/neu Expression in Breast Cancer with Various Clinicopathologic Factors.Rising global burden of breast cancer: the case of sub-Saharan Africa (with emphasis on Nigeria) and implications for regional development: a review.No difference in the prevalence of benign breast changes between women from Ghana and Norway: an autopsy study.Frequency of 5382insC mutation of BRCA1 gene among breast cancer patients: an experience from Eastern India.Molecular Biology of Breast Cancer in the Horn of Africa: Case Series—A Pilot Study of Breast Cancer from Eritrea
P2860
Q30316958-FD014CD6-B4A4-4552-BC27-FCC6CECC7D9BQ30317583-5339A6F4-D6EB-401C-9C8F-FBC3D63BB4D2Q33575459-15353648-7081-487E-8388-CAC723B41857Q33584351-A7985A65-2641-48C9-8FBD-45A9E9710C8EQ33622597-029986F4-1B45-4FCC-9B07-1FE5604DD6EFQ34052674-F0267541-C31B-4673-B2AC-ABE126014F68Q34155727-9FD14991-B4E4-4836-8CB9-7067DF537BEDQ34307263-A7BB3162-A8C8-4E25-BAAA-67E27BB5CF9EQ34423489-8D96EC87-AF6A-4BF4-BAFF-85D35605500CQ34512811-808ED994-653F-4B4A-9F21-5887659F74A1Q35042063-84461DBE-B9F5-4E5E-88C3-E1A27F910A68Q35122066-1D70F486-43C7-43E3-9630-4D3F18E1E99EQ35360144-73CB2317-4154-4DCE-A121-780350C9CDEEQ35687586-9282FCF6-90D1-4248-A40A-A73B5E54A71AQ35952998-8BBC90DE-1991-4DF6-B622-430ABCC5E13DQ35964064-8B779E27-011E-4D5A-A700-ECFBBB14FC62Q36244761-1C577A7B-199E-40AD-BBE1-FF4A3FB484E4Q36494156-8A909B81-A6F3-4780-8CEA-120CD987596FQ36997747-A8C444F6-CC98-4205-8E88-DEC7A93FD104Q37132777-D234B5D3-12BC-4C19-BEDC-C1EF52841929Q37132779-59566A40-B4A2-4C9F-8E78-1808D8F12762Q37369809-C8208978-A23B-4B38-B7D5-1D32FB161B09Q37425883-CA071CB7-8C95-4B80-A253-2D8079A987C9Q37690714-8F726868-0F18-4E32-8F0F-6BDB28D14DB0Q37976577-B1BE10D9-D996-4859-B6AD-8C2F0B959E14Q38202689-63027D70-5F2F-472F-8640-7DBD3755617BQ38644673-D59B96F0-170B-4DDF-AE6D-F98163298041Q41545885-8DB92824-DB5E-4DE7-A8D0-8B4814B50506Q42510389-A0D356E3-AE19-46C2-8D7C-AF49AC20516CQ44388577-EECB532B-A2D2-4A88-B348-0C33763283EBQ46163450-FAF3D6EF-2C2B-4241-AC68-4E11D06F9084Q46931484-7B7D0E58-1240-4D15-98F5-E00BF56B2D8DQ49879088-1A955632-B1E4-4387-8F68-7E022A9536BDQ52642389-8C21751F-548E-430A-9F18-E5B3E9B051FCQ53536766-2AB2321C-E513-418A-A345-D42C10938F21Q54279806-5C29A095-329C-4E5B-8B83-3E2EA8F91BCBQ58998750-AD7ED173-8C91-4E5E-957D-14DF184E7292
P2860
Immunohistochemical and molecular subtypes of breast cancer in Nigeria.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Immunohistochemical and molecular subtypes of breast cancer in Nigeria.
@en
Immunohistochemical and molecular subtypes of breast cancer in Nigeria.
@nl
type
label
Immunohistochemical and molecular subtypes of breast cancer in Nigeria.
@en
Immunohistochemical and molecular subtypes of breast cancer in Nigeria.
@nl
prefLabel
Immunohistochemical and molecular subtypes of breast cancer in Nigeria.
@en
Immunohistochemical and molecular subtypes of breast cancer in Nigeria.
@nl
P2093
P50
P1476
Immunohistochemical and molecular subtypes of breast cancer in Nigeria.
@en
P2093
Ayotunde Famooto
Chibuzor Nkwodimmah
Toyin Aniagwu
P2888
P304
P356
10.1007/S10549-007-9694-5
P407
P577
2007-08-03T00:00:00Z
P6179
1013659181